Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
2.550
+0.260 (11.35%)
At close: Jun 26, 2026, 4:00 PM EDT
2.559
+0.009 (0.37%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Lexicon Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lexicon Pharmaceuticals stock have an average target of 4.03, with a low estimate of 1.00 and a high estimate of 6.00. The average target predicts an increase of 58.04% from the current stock price of 2.55.
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Lexicon Pharmaceuticals stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $2.3 → $3.1 | Buy | Maintains | $2.3 → $3.1 | +21.57% | May 11, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $6 | Buy | Maintains | $6 | +135.29% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 | Buy | Maintains | $6 | +135.29% | Apr 15, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $1 | Hold | Reiterates | $1 | -60.78% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
38.17M
from 49.80M
Decreased by -23.37%
Revenue Next Year
20.15M
from 38.17M
Decreased by -47.20%
EPS This Year
-0.16
from -0.14
EPS Next Year
-0.21
from -0.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 44.8M | 58.5M | |
| Avg | 38.2M | 20.2M | |
| Low | 31.1M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -10.0% | 53.3% | |
| Avg | -23.4% | -47.2% | |
| Low | -37.5% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.14 | -0.11 | |
| Avg | -0.16 | -0.21 | |
| Low | -0.18 | -0.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.